392 jobs for “Pharmaceuticals”
GSK Siena, Italy €81,750 – €136,250 pa
Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting signals and delivering benefit-risk recommendations. Represents Safety on cross-functional matrix teams and governance committees, and interacts with regulators. Hybrid role based in the UK.
GSK Warsaw, Poland
Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering benefit-risk recommendations. Represents Safety on cross-functional matrix teams and governance committees, and interacts with regulators and external experts. Hybrid role based in the UK with a global matrix environment.
GSK Durham Blackwell Street US$188,100 – US$313,500 pa
Leads quantitative systems pharmacology and QST modelling within a clinical pharmacology and quantitative medicine group, building mechanistic models of disease and drug action and running simulations to assess trial design. Defines and coordinates MIDD strategies across respiratory, immunology and inflammation programmes, working with biologists, clinicians, pharmacometricians and AI/ML specialists. The role sits in a newly established Centre of Excellence for model-informed drug development.
GSK Zug, Switzerland US$222,750 – US$371,250 pa
Serves as the physician within a clinical programme team, leading medical monitoring, safety oversight and data interpretation for GI oncology studies. Partners with a Senior Scientist and cross-functional matrix teams on protocol development, regulatory interactions and investigator engagement. Requires an on-site presence 2-3 days a week across UK, Swiss or US sites.
GSK Warsaw, Poland US$284,250 – US$473,750 pa
Leads clinical development of GU oncology assets, designing and executing Phase 1-3 trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and contributes to business development diligence.
GSK London US$242,550 – US$404,250 pa
Senior physician leader providing medical oversight, safety monitoring and clinical data interpretation across lung cancer studies within a clinical programme team. Partners with the Senior Scientist and cross-functional groups on protocol design, regulatory interactions and external scientific engagement, while mentoring Medical Directors. Requires an on-site presence at least two days a week.
GSK London US$340,500 – US$567,500 pa
Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability and chairing a cross-functional matrix Medicine Development Team spanning clinical, translational, regulatory, manufacturing and commercial. Drives strategy, go/no-go decisions and lifecycle plans for novel vaccine platforms such as mRNA and neoantigen-based therapies.
GSK Waltham, United States US$340,500 – US$567,500 pa
Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and represents the asset to senior governance boards.
GSK Stevenage US$340,500 – US$567,500 pa
Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability. Builds and leads a matrix Medicine Development Team spanning clinical development, immunology, manufacturing, regulatory, safety, medical affairs and commercial, and sets the asset strategy within GSK's oncology R&D portfolio.
GSK Zug, Switzerland US$340,500 – US$567,500 pa
Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and serves as asset spokesperson to senior governance boards.
GSK London US$222,750 – US$371,250 pa
Provides clinical and scientific leadership across cardiovascular clinical development programmes, shaping study designs, translational plans and regulatory documents within the Respiratory, Immunology & Inflammation Research Unit. Leads a Clinical Matrix Team, oversees participant safety and medical monitoring, and works cross-functionally with biology, regulatory, statistics and commercial partners. Hybrid working with at least two days per week on-site.
GSK Waltham, United States US$222,750 – US$371,250 pa
Leads clinical development strategy for cardiovascular assets within the Respiratory, Immunology & Inflammation Research Unit, designing clinical development plans, protocols and regulatory documents while providing medical monitoring and safety oversight. Chairs the Clinical Matrix Team and serves as primary clinical contact for regulators, investigators and key external experts across early and late-stage programs.
GSK Stevenage US$222,750 – US$371,250 pa
Provides clinical and scientific leadership across early-phase cardiovascular programs, shaping clinical development plans, study designs and regulatory documents. Leads a cross-functional Clinical Matrix Team, oversees medical monitoring and safety, and acts as the clinical point of contact for regulators, investigators and key external experts. Hybrid role with at least two days per week on-site.
GSK Waltham, United States US$204,000 – US$340,000 pa
Leads the design and execution of real-world evidence and health outcomes studies for oncology assets, managing timelines, budgets and quality of protocols, analyses and publications. Advises internal medical, market access and commercial teams and external experts on evidence strategy for HTA submissions, reimbursement and value-based pricing. Requires close collaboration across a matrix and deep knowledge of real-world data sources and payer needs.
GSK London US$204,000 – US$340,000 pa
Leads the design and execution of real-world evidence and health outcomes studies across oncology assets, managing timelines, budgets and quality of protocols, analyses and publications. Advises internal medical, market access and commercial teams and external experts on evidence strategy for HTA submissions, reimbursement and value-based pricing, while building knowledge of real-world data sources and payer needs.
